Table 2 Baseline characteristics and DHA levels of study participants
Variable a | All participants | Participants who provided a follow-up sample |
|---|---|---|
N | 84 | 60 |
Age (years) | 30 (27, 32) | 30 (27, 32) |
Pre-pregnancy BMI (kg/m2) | 24.2 (21.7, 28.1) | 23.6 (21.1, 26.6) |
Race/Ethnicity (% White/Caucasian) | 99% (83) | 98% (59) |
Education (Associates Degree or more) | 87% (73) | 85% (51) |
Parity (number of pregnancies) | 2 (1, 3) | 2 (1, 3) |
Gestation length (weeks) | 39 (38, 40) | 39 (38, 40) |
Lactation length (weeks) | 15.3 (6.0, 28.8) | 12.0 (6.0, 22.8) |
Pregnancy weight gain (kg) | 15.9 (13.6, 22.7) | 15.9 (13.6, 23.8) |
Percent of mothers who had diabetes during pregnancy (n) | 7% (6) | 7% (4) |
Percent of mothers supplementing with DHA during lactation (baseline; n) | 51% (43) | 53% (32) |
Percent of mothers who supplemented with DHA during pregnancy (n) | 72% (59) | 71% (42) |
Breast milk DHA level (% of total fatty acids) | 0.18% (0.13, 0.28) | 0.19% (0.15, 0.30) |
Percent of mothers with milk DHA ≥ 0.32% (Worldwide Average b; n) | 17% (14) | 18% (11) |